A new selection method to increase the health benefits of CVD prevention strategies.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsLagerweij, Ghizelda R
de Wit, G Ardine
Moons, Karel Gm
van der Schouw, Yvonne T
Verschuren, Wm Monique
Dorresteijn, Jannick An
MetadataShow full item record
TitleA new selection method to increase the health benefits of CVD prevention strategies.
Published inEur J Prev Cardiol 2018; 25(6):642-50
PubliekssamenvattingBackground Cardiovascular disease (CVD) prevention is commonly focused on providing individuals at high predicted CVD risk with preventive medication. Whereas CVD risk increases rapidly with age, current risk-based selection of individuals mainly targets the elderly. However, the lifelong (preventable) consequences of CVD events may be larger in younger individuals. The purpose of this paper is to investigate if health benefits from preventive treatment may increase when the selection strategy is further optimised. Methods Data from three Dutch cohorts were combined ( n = 47469, men:women 1:1.92) and classified into subgroups based on age and gender. The Framingham global risk score was used to estimate 10-year CVD risk. The associated lifelong burden of CVD events according to this 10-year CVD risk was expressed as quality-adjusted life years lost. Based on this approach, the additional health benefits from preventive treatment, reducing this 10-year CVD risk, from selecting individuals based on their expected CVD burden rather than their expected CVD risk were estimated. These benefits were expressed as quality-adjusted life years gained over lifetime. Results When using the current selection strategy (10% risk threshold), 32% of the individuals were selected for preventive treatment. When the same proportion was selected based on burden, more younger and fewer older individuals would receive treatment. Across all individuals, the gain in quality-adjusted life years was 217 between the two strategies, over a 10-year time horizon. In addition, when combining the strategies 5% extra eligible individuals were selected resulting in a gain of 628 quality-adjusted life years. Conclusion Improvement of the selection approach of individuals can help to reduce further the CVD burden. Selecting individuals for preventive treatment based on their expected CVD burden will provide more younger and fewer older individuals with treatment, and will reduce the overall CVD burden.
- [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
- Authors: Si YQ, Tang X, Zhang DD, He L, Cao Y, Wang JW, Li N, Liu JJ, Gao P, Hu YH
- Issue date: 2018 Jun 18
- Predicted burden could replace predicted risk in preventive strategies for cardiovascular disease.
- Authors: Lagerweij GR, de Wit GA, Moons KGM, Verschuren WMM, Boer JMA, Koffijberg H
- Issue date: 2018 Jan
- Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study.
- Authors: Crossan C, Lord J, Ryan R, Nherera L, Marshall T
- Issue date: 2017 Jan
- Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.
- Authors: Ferket BS, Hunink MG, Khanji M, Agarwal I, Fleischmann KE, Petersen SE
- Issue date: 2017 Apr
- A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
- Authors: Yu J, Shah BM, Ip EJ, Chan J
- Issue date: 2013 Mar